Founded in 2019, Gnosis Neurodynamics was initiated by scientists Bo Hong, Bai Lu and Hongjiang Zhang. With roots in Tsinghua University's neuroengineering research, we connect brain data and foundation models with clinical applications.
Our three business areas are clinical BCI data and intelligent care platforms, precision neurotechnology, and individual digital brains for CNS drug research. Beijing focuses on model research, Xiong'an on innovation demonstrations, and Shanghai on application and translation.
Scientific Team
Bringing together neural engineering, neurobiology and artificial intelligence.
Chief Scientist
Hong Bo
Professor at Tsinghua University’s School of Biomedical Engineering. His work connects brain–computer interfaces, language intelligence and interventions for brain disorders.
Chief Scientist
Bai Lu
Professor at Tsinghua University’s School of Pharmaceutical Sciences and director of the Shanghai Institute for Advanced Study of Natural Sciences. His research focuses on neurobiology and neurological therapeutics.
Chief Scientist
Hongjiang Zhang
Member of the US National Academy of Engineering and a founding member of Microsoft Research Asia. His work connects artificial intelligence, multimedia computing and brain data.
Founder & research roots
Yuxiang Yan · Founder, Chairman & CEO
Dr. Yan holds a PhD in Biomedical Engineering from Tsinghua University, with joint doctoral training at Harvard and visiting research at Massachusetts General Hospital. He founded Gnosis Neurodynamics in 2019.
His research spans AI analysis of brain function, clinical neurophysiology, multimodal imaging and individual digital brain modeling.
Our team connects neural engineering with software, hardware and clinical collaboration.
Company News
BPD 2026 · Shanghai
On August 6–7, 2026, Gnosis Neurodynamics joined the ninth Biopharmaceutical Process Development conference in Shanghai. Dr. Yuxiang Yan presented digital human brain modeling for innovative CNS drug research.
The team is exploring EEG digital biomarkers and virtual interventions for individualized brain modeling, patient stratification and treatment evaluation.
We continue to exchange ideas with clinical and industry partners to connect neuroscience and data technology with real research needs.
Our journey
From clinical needs to brain data, neurodynamic models and product applications.
2019–2020 · Foundations
2019 · Gnosis Neurodynamics is founded, connecting neuroengineering with clinical translation.
2020 · Multicenter EEG and BCI clinical research begins.
2021–2023 · Data & products
2021 · EEG data and decoding model research.
2022 · EEG analysis product registration and translation.
2023 · EEG AI data centers and quantitative brain research.
2024–2026 · Digital brains
2024 · Neurodynamic digital brains and CNS drug research.
2025 · Virtual intervention and brain health research.
2026 · NeuroFusion, multimodal platforms and BCI clinical scenarios.
Partner network
Working across clinical care, research and industry to advance brain science.
